Health
PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs – Technology Networks
Scientists have shown that PD-L1 is a potential anti-cancer therapy target for the treatment of metastasized oral malignant melanoma in dogs.
Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.
There are a number of cancers that affect dogs, but there are far fewer diagnosis and treatment options for these canine cancers. However, as dogs and humans are both mammals, it is likely that strategies and treatments for cancers in humans can be used for canine cancer, with minor modifications.
A team of scientists, including Associate Professor Satoru…
-
General13 hours agoMan arrested after alleged carjackings, dramatic pursuit in Melbourne CBD
-
General16 hours agoSix NRL players named in England rugby league Ashes sqaud, Man of Steel winner not selected
-
Noosa News19 hours agoOpera brilliance in Noosa | Noosa Today
-
Business16 hours agoBuy these ASX dividend shares for 4% to 6% yields